A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NLCs / nanostructured lipid carriers

[Related PubMed/MEDLINE]
Total Number of Papers: 394
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NLCs  (>> Co-occurring Abbreviation)
Long Form:   nanostructured lipid carriers
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity. GX1-PTX-NLCs, PTX
2020 A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability. cNLCs, cSLNs, SLNs
2020 A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. BC, EGFR, ER, HER2, PR, SLNs, TNBC, VEGF
2020 Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. PDA, RP-HPLC
2020 Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives. ---
2020 Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. BBR, BBR-NLCs, UC
2020 beta-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity. ---
2020 Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator. DOX
2020 Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment. CL, MRT
10  2020 Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis. ---
11  2020 Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells. ---
12  2020 Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule. ALM, CNS, EE, ZP
13  2020 Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing. CHI, NA
14  2020 Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment. ---
15  2020 Development of folic acid-loaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation. FA, UV
16  2020 Development of Nanostructured Lipid Carriers for the Delivery of Idebenone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. BBB, IDE, ROS, SACS
17  2020 Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy? DEX, LAs, LEV, LPNs, Tat
18  2020 Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats. EE, NSAIDs, PDI, TNX
19  2020 Ellagic Acid Containing Nanostructured Lipid Carriers for Topical Application: A Preliminary Study. EA, FRAP, SAXS
20  2020 Encapsulation of Oleuropein in Nanostructured Lipid Carriers: Biocompatibility and Antioxidant Efficacy in Lung Epithelial Cells. OLE
21  2020 Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application. DSC, PK, SEM, XRD, ZT, ZT-CS
22  2020 Enhanced Transdermal Delivery of Concentrated Capsaicin from Chili Extract-Loaded Lipid Nanoparticles with Reduced Skin Irritation. EE, HET-CAM, LC, SLNs
23  2020 Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy. SLNs
24  2020 Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells. SEM
25  2020 Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. APM, PDI, ZP
26  2020 Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier. GMD
27  2020 Lipid Nanoparticles as a Skin Wound Healing Drug Delivery System: Discoveries and Advances. LNPs, SLNs
28  2020 Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol. SLNs
29  2020 Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. COX-2
30  2020 Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies. SFN, TAM
31  2020 Luliconazole-loaded Nanostructured Lipid Carriers for Topical Treatment of Superficial Tinea infections. ---
32  2020 Multiple Response Optimization of Beeswax-Based Nanostructured Lipid Carriers for the Controlled Release of Vitamin E. MCTs, NLC-VE
33  2020 Mussel-Inspired Polydopamine Coating Enhances the Intracutaneous Drug Delivery from Nanostructured Lipid Carriers Dependently on a Follicular Pathway. HaCaT, PDA, TBF
34  2020 Nanolipoidal alpha-terpineol modulates quorum sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa. alphaT
35  2020 Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis. LNZ, TP
36  2020 Nanostructured Lipid Carriers (NLCs) for drug delivery: Role of Liquid lipid (oil). ---
37  2020 Nanostructured Lipid Carriers (Nlcs): Nose-to-Brain Delivery and Theranostic Application. ---
38  2020 Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders. ---
39  2020 Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. SLNs
40  2020 Nanostructured Lipid Carriers Made of Omega-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases. CNS, CS, DDS, LPS, ND, PDI
41  2020 Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study. ---
42  2020 Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. GI, TMS
43  2020 Nanostructured lipid carriers- A versatile carrier for oral delivery of lipophilic drugs. ---
44  2020 Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery. ---
45  2020 Nanostructured lipid carriers: A novel hair protective product preventing hair damage and discoloration from UV radiation and thermal treatment. Vit E-NLCs
46  2020 Optimization of Rifapentine-Loaded Lipid Nanoparticles Using a Quality-by-Design Strategy. EE, LC, RPT, TB
47  2020 Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin. FLB
48  2020 Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers. DSC, EE, RLX
49  2020 Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. IBD, OLE, ROS
50  2020 Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis. RLX, Vit.D
51  2020 Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. SLNs
52  2020 Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent. SAL
53  2020 Pumpkin Oil-Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats. LL, NSAID, PSO
54  2020 QbD-driven development of intranasal lipid nanoparticles for depression treatment. CQAs
55  2020 Resveratrol: Isolation, and Its Nanostructured, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity. CSNLCs, LDH, MCF-7, RES
56  2020 S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties. EE, LC, PDI
57  2020 Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect. CUR, TMZ
58  2020 Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. BBB, CNS, GBM, SLNs
59  2020 Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers. AmB
60  2020 Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity. DDS, DLS, DM, ELS, HPH, NLC, PI, ZP
61  2020 Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies. DL, FA
62  2020 Synthesis of Tilmicosin Nanostructured Lipid Carriers for Improved Oral Delivery in Broilers: Physiochemical Characterization and Cellular Permeation. P-pg, TMS
63  2020 The influence of oil composition on the transformation, bioaccessibility, and intestinal absorption of curcumin in nanostructured lipid carriers. CUR, GTS, MCT
64  2020 [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application]. ---
65  2019 A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer. COX-2, ETD, N-Phsoms, P-Phsoms, PCNA-mRNA, SCC
66  2019 Accelerated infected wound healing by topical application of encapsulated Rosemary essential oil into nanostructured lipid carriers. REO
67  2019 Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. AmB, DSC, FT-IR, HSM, PXRD, SLNs
68  2019 Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations. ASPM
69  2019 Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. CNS, SLNs
70  2019 Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis. ChS, CS, LEF, RA
71  2019 Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice. PTX
72  2019 Compatibility analysis of bergapten with different pharmaceutical excipients used in nanostructured lipid carriers. FTIR, NPs
73  2019 Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. CUR, PS, RSM, ZP
74  2019 Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting. CPA
75  2019 Data on optimization and drug release kinetics of nanostructured lipid carriers containing ondansetron hydrochloride prepared by cold high-pressure homogenization method. DL, EE, OSH, PI, PS
76  2019 Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use. DXM
77  2019 Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. DPB, NLC gel
78  2019 Development of MART for the Rapid Production of Nanostructured Lipid Carriers Loaded with All-Trans Retinoic Acid for Dermal Delivery. ANN, ATRA, GA, MART, RSM
79  2019 Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. BBB, KETO
80  2019 Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration. M-NLC, PDI, ZP
81  2019 Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. IMQ, PASI, PDI
82  2019 Effect of lipid chain length on nanostructured lipid carriers: Comprehensive structural evaluation by scattering techniques. DLS, SANS, SLS, solid phases
83  2019 Effect of Oil Content on Physiochemical Characteristics of gamma-Oryzanol-Loaded Nanostructured Lipid Carriers. DFM, DSC, FTIR, GO, TEM, XRD
84  2019 Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study. AMS
85  2019 Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. CPP, CPPs, LN
86  2019 Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems. ERT
87  2019 Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions. ---
88  2019 Experimental validation of biocompatible nanostructured lipid carriers of sophorolipid: Optimization, characterization and in-vitro evaluation. AFM, SANS, SEM, TEM
89  2019 Fabrication and characterization of nanostructured lipid carriers (NLC) using a plant-based emulsifier: Quillaja saponin. DSC, HSO, NLC, O/W, SLNs, TEM
90  2019 Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design. EE, NLC, PDI, PPD
91  2019 Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. GPs
92  2019 Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations. LPV, PDI, PS, ZP
93  2019 Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model. ---
94  2019 Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies. ---
95  2019 Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles. CsA, SLNs
96  2019 In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. CUR, Cur-NLC, DDSs, PI, TEM
97  2019 Lipid-based nano delivery of antimicrobials to control food-borne bacteria. SLNs
98  2019 Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo. LAs, PLA NPs, SLNs, TTC
99  2019 Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea. MTZ
100  2019 Multifunctional green supramolecular solvents for cost-effective production of highly stable astaxanthin-rich formulations from Haematococcus pluvialis. SUPRAS